Whole-body MRI and diffusion-weighted imaging in malignant lymphomas

Congress:

ECR 2013

Poster Number:

C-1360

Type:

Scientific Exhibit

Keywords:

Lymph nodes, Oncology, Mediastinum, CT-Angiography, MR, MR-Diffusion/Perfusion, Chemotherapy, Comparative studies, Diagnostic procedure, Haematologic diseases, Lymphoma

Authors:

A. Mikhaylov, V. Panov, I. E. Tyurin; Moscow/RU

DOI:

10.1594/ecr2013/C-1360

DOI-Link:

https://dx.doi.org/10.1594/ecr2013/C-1360

References

Gerwin Schmidt, Dietmar Dinter, Stefan Schoenberg Whole-body MRI chapter in Clinical MR-imaging (2010)
Ruth Eichner, Klaus Wörtler, Markus Essler, Martina Rudelius, Christian Peschel, Ingo Ringshausen, Katharina GötzeSymmetric multifocal bone marrow involvement diagnosed by whole-body magnetic resonance imaging in a patient with B lymphoblastic lymphoma. Ann Hematol (2013)
Thomas C. Kwee, Taro Takahara, Malou A. Vermoolen, Marc B. Bierings, Willem P. Mali, Rutger A. J. Nievelstein Whole-body diffusion-weighted imaging for staging malignant lymphoma in children. Pediatr Radiol. 2010
Schmidt G, Reiser M, Baur-Melnyk A. Whole-body MRI for the staging and follow-up of patients with metastasis. EJR. 2009.
Stecco A, Romano G, Negru M, et al. Whole-body diffusion-weighted
magnetic resonance imaging in the staging of oncological patients: comparison with positron emission tomography computed tomography (PET-CT) in a pilot study. Radiol med. 2009.
Chua SC, Rozalli FI, O'Conner SR. Imaging features of primary extranodal lymphomas. Clinical Radiology. 2009.
Dyler R, DiSantis DJ, McClennan BL. Simplified Imaging Approach for the evaluation of the Solid Renal Mass in Adults. Radiology. 2008
Kwee TC, Kwee RM, Nievelstein RA. Imaging in staging of malignant lymphoma: a systematic review. Blood. 2008.
Lichy MP, Aschoff P, Plathow C, et al. Tumor detection by diffusion-weighted MRI and ADC-maping_initial clinical experiences in comparison to PET/CT. Invest Radiol. 2007.
Dähnert W. Radiology Review Manual (6th Ed). Lippincott Williams and Wilkins. 2007.
Ghai S, Pattison J et al. Primary Gastro-Intestinal Lymphoma: Spectrum of Imaging Findings with Pathologic correlation. Radiographics. 2007.
Leite NP, Kased N, Hanna RF, et al. Cross-sectional imaging of extranodal involvement in abdominopelvic lymphoproliferative malignancies. RadioGraphics. 2007.
Schlemmer HP, Schafer J, Pfannenberg C, et al. Fast whole-body assessment of metastatic disease using a novel magnetic resonance imaging system:initial experiences. Invest Radiol. 2005
Kazama T, FariaSC, Varavithya V, et al. FDG-PET in the evaluation of
treatment for lymphoma: clinical usefulness and pitfalls. Radiographics.
2005.
Divgi C. Imaging, staging, and evaluation of lymphoma using nuclear
medicine. Semin Oncol. 2005
Kellenberger CJ, Miller SF, Khan M, et al. Initial experience with FSE STIR
whole-body MR imaging for staging lymphoma in children. Eur Radiol. 2004.
Lauenstein TC, Goehde SC, Herborn CU, et al. Whole-body MR
imaging:evaluation of patients for metastases. Radiology. 2004
BurtonC, Ell P, Linch D. The role of PET imaging in lymphoma. Br J
Hematol. 2004
Kavanagh E, Smith C, Eustace S. Whole-body turbo STIR MR
imaging;controversies and avenues for development. Eur Radiol. 2003
Krishnan A, Shirkhoda A, Tehranzadeh J, Armin AR, Irwin R, Les K. Primary Bone Lymphoma: Radiographic–MR Imaging Correlation. Radiographics. 2003
Walker RE, Eustace SJ. Whole-body magnetic resonance imaging:
techniques, clinical indications, and future applications. Semin
Musculoskelet Radiol. 2001
Montraves F, McNamara D, Landaman-Parker J, et al. FDG in childhood
lymphoma: clinical utility and impact on management. Eur J Nucl Med Mol
Imaging. 2002
Walker R, Kessar P, Blanchard R, et al.. Turbo STIR magnetic resonance
imaging as awhole-body screening tool for metastases in patients with
breast carcinoma: preliminary clinical experience. J Magn Reson Imaging.
2000.